VAERS Explorer
Back to explore

Report #2835550

Received Apr 10, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
—
Recovered
Recovered
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (2)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (NO BRAND NAME)UNKNOWN MANUFACTURER2UNK—
VARZOSZOSTER (NO BRAND NAME)UNKNOWN MANUFACTURER1UNK—

Symptoms (3)

Herpes zosterInappropriate schedule of product administrationVaccination failure

Symptom narrative

took booster dose and stil got shingles/ suspected vaccination failure; had the original and several decades later a booster; shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (Verbatim: took booster dose and stil got shingles/ suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: shingles) and drug dose administration interval too long (Verbatim: had the original and several decades later a booster). The outcome of the vaccination failure was not reported and the outcome of the shingles was resolved (duration 3 days) and the outcome of the drug dose administration interval too long was not applicable. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine. The company considered the vaccination failure to be unrelated to Shingles vaccine and Shingles vaccine. It was unknown if the company considered the shingles to be related to Shingles vaccine and Shingles vaccine. Additional Information: GSK Receipt Date: 02-APR-2025 This case was reported by a patient via interactive digital media. Patient had the original and several decades later a booster shingles vaccine and still got shingles, but it was less severe and cleared in about 3 days. The patient received 2nd dose of Shingles vaccine later than the recommended schedule, which led to lengthening of vaccination schedule. This case was considered as suspected vaccination failure as details regarding completion time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting.; Sender's Comments: Vaccination failure is a listed event which, due to the following criteria (insufficient information provided about time to onset for shingles, completion of primary vaccination schedule and laboratory confirmation regarding shingles) is considered unrelated to GSK vaccine Shingles vaccine (Dose 1& 2).